Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries. 1986

I Jansen, and R Uddman, and M Hocherman, and R Ekman, and K Jensen, and J Olesen, and P Stiernholm, and L Edvinsson

Nerve fibers containing neuropeptide Y (NPY), vasoactive intestinal polypeptide (VIP), substance P (SP), and calcitonin gene-related peptide (CGRP) were seen in the adventitia or at the adventitia-media border of the human temporal artery. Pharmacological experiments on isolated temporal artery segments revealed that NPY potentiated the vasoconstrictor responses to noradrenaline, but had no vasoconstrictor ability or only a small vasoconstrictor ability per se. VIP, peptide histidine methionine 27 (PHM-27), SP, neurokinin A (NKA), and CGRP potently relaxed vessels precontracted by prostaglandin F2 alpha, the relative potency being CGRP greater than SP greater than NKA = VIP = PHM-27. The amount of relaxation varied between 67 and 91% of the prostaglandin F2 alpha-induced contraction. The peptide effects were not antagonized by classic adrenergic or cholinergic blockers, suggesting interactions via separate receptor sites.

UI MeSH Term Description Entries
D009478 Neuropeptide Y A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. Neuropeptide Y-Like Immunoreactive Peptide,Neuropeptide Tyrosine,Neuropeptide Y Like Immunoreactive Peptide,Tyrosine, Neuropeptide
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013373 Substance P An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses. Euler-Gaddum Substance P,Hypothalamic Substance P,SP(1-11),Euler Gaddum Substance P,Substance P, Euler-Gaddum,Substance P, Hypothalamic
D013699 Temporal Arteries Arteries arising from the external carotid or the maxillary artery and distributing to the temporal region. Arteries, Temporal,Artery, Temporal,Temporal Artery
D014660 Vasoactive Intestinal Peptide A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE). VIP (Vasoactive Intestinal Peptide),Vasoactive Intestinal Polypeptide,Vasointestinal Peptide,Intestinal Peptide, Vasoactive,Intestinal Polypeptide, Vasoactive,Peptide, Vasoactive Intestinal,Peptide, Vasointestinal,Polypeptide, Vasoactive Intestinal
D015740 Calcitonin Gene-Related Peptide A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator. Calcitonin Gene-Related Peptide I,Calcitonin Gene-Related Peptide II,alpha-CGRP,alpha-Calcitonin Gene-Related Peptide,beta-CGRP,beta-Calcitonin Gene-Related Peptide,Calcitonin Gene Related Peptide,Calcitonin Gene Related Peptide I,Calcitonin Gene Related Peptide II,Gene-Related Peptide, Calcitonin,alpha Calcitonin Gene Related Peptide,beta Calcitonin Gene Related Peptide
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

I Jansen, and R Uddman, and M Hocherman, and R Ekman, and K Jensen, and J Olesen, and P Stiernholm, and L Edvinsson
January 1988, Histochemistry,
I Jansen, and R Uddman, and M Hocherman, and R Ekman, and K Jensen, and J Olesen, and P Stiernholm, and L Edvinsson
August 1994, Journal of the autonomic nervous system,
I Jansen, and R Uddman, and M Hocherman, and R Ekman, and K Jensen, and J Olesen, and P Stiernholm, and L Edvinsson
May 2006, International endodontic journal,
I Jansen, and R Uddman, and M Hocherman, and R Ekman, and K Jensen, and J Olesen, and P Stiernholm, and L Edvinsson
January 1996, Research in veterinary science,
I Jansen, and R Uddman, and M Hocherman, and R Ekman, and K Jensen, and J Olesen, and P Stiernholm, and L Edvinsson
December 1991, Surgery,
I Jansen, and R Uddman, and M Hocherman, and R Ekman, and K Jensen, and J Olesen, and P Stiernholm, and L Edvinsson
October 2002, Neuropeptides,
I Jansen, and R Uddman, and M Hocherman, and R Ekman, and K Jensen, and J Olesen, and P Stiernholm, and L Edvinsson
December 1988, Journal of neurosurgery,
I Jansen, and R Uddman, and M Hocherman, and R Ekman, and K Jensen, and J Olesen, and P Stiernholm, and L Edvinsson
June 1999, Neuropeptides,
I Jansen, and R Uddman, and M Hocherman, and R Ekman, and K Jensen, and J Olesen, and P Stiernholm, and L Edvinsson
January 2008, Journal of musculoskeletal & neuronal interactions,
I Jansen, and R Uddman, and M Hocherman, and R Ekman, and K Jensen, and J Olesen, and P Stiernholm, and L Edvinsson
August 1998, Neurogastroenterology and motility,
Copied contents to your clipboard!